@Arizona and @Remorhaz I agree. This entirely in line with the plan.
It hardly warrants a 6+% kicker in the SP. And I think this is just an indication of how jittery the market is on this stock.
The only real next information that matters is the product sales that will be reported in 2025. However, if they indicate that there is a good product-market fit here, with patients signing up and then taking refills, then these bounces on what I call "soft news" are only a precursor to what we might see next year.
Of all my holdings, $BOT has the largest upside potential in 2025.
Disc. Held